Direct-to-consumer devices promising pain relief are flooding the market. Is there enough evidence to recommend these devices to patients with chronic pain?

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing ...

TENS-electrical-therapy_G_505722027 Transcutaneous electrical nerve stimulation may be ineffective in treating, relieving lower back pain when compared with other nerve stimulation therapies.

Transcutaneous Electrical Nerve Stimulation (TENS) is a widely investigated non‐invasive modality for alleviating both acute and chronic pain. By delivering controlled electrical impulses via surface ...

Percutaneous peripheral nerve stimulation significantly improved pain and decreased opioid requirements for at least a week after ambulatory orthopedic surgery, according to the results of a pilot ...

Four weeks of active transcutaneous electrical nerve stimulation, or TENS, can significantly improve pain triggered by movement and other clinical outcomes among women with fibromyalgia, according to ...

It’s ridiculously easy to take a bad photograph. Your brain is a far better Photoshop than Photoshop, and the amount of editing it does on the scenes your eyes capture often results in marked and ...

April 15 (UPI) --Nerve stimulation treatments are effective for reducing pain in patients recovering from orthopedic surgery and limit the need for potentially addictive opioid medications, a study ...

Imbalanced autonomic function, characterized by reduced vagal activity and sympathetic dominance, is increasingly recognized in various gastrointestinal (GI) disorders. The vagus nerve, a key ...

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children ...